Blog

Beyond CBCs: Advanced blood tests for detecting cancer

The number of new cancer cases diagnosed each year is staggering. In 2024, there will be an estimated 2 million new cases of cancer in the United States. Early detection is crucial, as it can significantly increase survival rates and improve treatment outcomes.

Blood tests can be a powerful ally in this fight against cancer. By providing valuable information about a person's health and potentially identifying early signs of the disease, blood tests can empower patients and doctors to take timely action. This can lead to earlier intervention, potentially less aggressive treatment options with fewer side effects, and ultimately, a better chance of successful treatment and a longer, healthier life.

A Complete Blood Count (CBC) is a common blood test that provides valuable information about a person's overall health, including red blood cell count, white blood cell count, and platelet levels. However, while CBCs play a vital role in routine health checks, their ability to detect cancer early is often limited. Abnormal results might not show up until later stages of the disease.

Need for more advanced detection methods

At RGCC, we believe in empowering patients with advanced tools for early cancer detection. Our liquid biopsies are innovative and advanced blood tests that offer a more precise and sensitive approach to potentially identify cancer at its earliest stages, even before traditional methods show any abnormalities.

How do liquid biopsies work?

Liquid biopsies analyze blood samples for:

Circulating Tumor Cells (CTCs): These are cancer cells that have broken away from a tumor and entered the bloodstream.
Circulating Tumor DNA (ctDNA): Fragments of DNA shed by cancer cells into the bloodstream.
Exosomes: Exosomes are tiny molecules released by various cells in the body, including cancer cells. They can contain proteins, DNA, and other molecules that might offer clues about the presence and characteristics of cancer.

By detecting these markers, liquid biopsies can provide valuable insights into potential cancer development, even before traditional methods show abnormalities.

Watch this video to learn more about RGCC’s liquid biopsies from our founder, Dr. Ioannis Papasotiriou.

What to expect during a liquid biopsy

A liquid biopsy is a relatively simple outpatient procedure. Here's what to expect:

Schedule a visit for a blood draw with an RGCC registered practitioner.
A healthcare professional will draw a small amount of blood from your arm.
The blood sample will then be sent to a laboratory for analysis.
You will typically receive the results of your liquid biopsy within a few weeks.

Advantages of advanced blood tests

Our liquid biopsies are a minimally invasive approach to potentially identify cancer at its earliest stages. They offer several additional advantages over traditional methods:

Liquid biopsies have the potential to detect cancer earlier than traditional methods, offering a window of opportunity for more effective treatment and improved outcomes.
Unlike some traditional diagnostic procedures, liquid biopsies require a simple blood draw, making them a more patient-friendly approach.
The information gleaned from liquid biopsies can help guide treatment decisions, potentially leading to more targeted therapies tailored to the specific characteristics of the patient's cancer.
Liquid biopsies can also be used to monitor a patient's response to cancer treatment and identify potential recurrence earlier.

RGCC's expertise in advanced blood tests

At RGCC, we are at the forefront of developing and using advanced liquid biopsy tests. Our range of tests offers a comprehensive approach to early cancer detection.

Onco-D-clare

The Onco-D-clare test analyzes gene expression patterns in your blood sample and offers the potential for early detection of various cancers even before symptoms arise. Early cancer detection allows for proactive management, increasing the chances of successful intervention and treatment.

Onconomics panels

Our Onconomics panels are blood tests that provide deeper insight into the possible treatment options that are likely to work best on your cancer. This personalized approach helps guide treatment decisions by identifying the most effective anti-cancer drugs, targeted therapies, or even natural substances for a patient's specific cancer.

CTC tests

Our CTC tests analyze blood samples to detect the presence and concentration of circulating tumor cells (CTCs). They are valuable for monitoring a patient's response to treatment and potentially identifying early signs of relapse.

These tests can be particularly valuable for individuals with:

A family history of cancer.
Known risk factors for specific cancers.
Confirmed cancer diagnosis.
A history of cancer, for monitoring purposes.

Take control of your health

Early detection is key in the fight against cancer. Discuss the possibility of advanced blood tests, like liquid biopsies, with your RGCC registered practitioner to see if they might be right for you. They can help you understand your individual risk factors and determine the best course of action for early detection and preventative measures.

By working collaboratively with your doctor and exploring the possibilities offered by our advanced blood tests, you can empower yourself with a more comprehensive understanding of your cancer and take a proactive approach to your diagnosis and treatment journey.

Contact us

Discover groundbreaking cancer testing solutions pioneered by RGCC, which throw light on the path toward better cancer care. We offer a paradigm shift in cancer care technologies and protocols.

Get in touch today to start your journey to empowering information for your cancer treatment by contacting us online.